$6.66
1.77% yesterday
Nasdaq, Jul 11, 10:00 pm CET
ISIN
US6024961012
Symbol
MDXG
Sector
Industry

MiMedx Group, Inc. Stock price

$6.66
+0.24 3.74% 1M
-1.90 22.20% 6M
-2.96 30.77% YTD
-0.45 6.33% 1Y
+3.20 92.49% 3Y
+1.66 33.20% 5Y
-5.45 45.00% 10Y
+6.56 6,560.00% 20Y
Nasdaq, Closing price Fri, Jul 11 2025
-0.12 1.77%
ISIN
US6024961012
Symbol
MDXG
Sector
Industry

Key metrics

Basic
Market capitalization
$983.7m
Enterprise Value
$895.9m
Net debt
positive
Cash
$106.4m
Shares outstanding
147.6m
Valuation (TTM | estimate)
P/E
24.7 | 26.3
P/S
2.8 | 2.6
EV/Sales
2.5 | 2.4
EV/FCF
13.9
P/B
4.9
Financial Health
Equity Ratio
73.2%
Return on Equity
22.0%
ROCE
19.9%
ROIC
22.0%
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
$352.4m | $382.2m
EBITDA
$46.0m | $79.2m
EBIT
$45.3m | $47.4m
Net Income
$40.2m | $38.0m
Free Cash Flow
$64.6m
Growth (TTM | estimate)
Revenue
5.3% | 9.6%
EBITDA
-18.4% | 51.6%
EBIT
-18.5% | -6.4%
Net Income
-35.7% | -10.4%
Free Cash Flow
88.9%
Margin (TTM | estimate)
Gross
81.9%
EBITDA
13.1% | 20.7%
EBIT
12.9%
Net
11.4% | 10.0%
Free Cash Flow
18.3%
More
EPS
$0.3
FCF per Share
$0.4
Short interest
4.2%
Employees
895
Rev per Employee
$390.0k
Show more

Is MiMedx Group, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,006 stocks worldwide.

MiMedx Group, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a MiMedx Group, Inc. forecast:

10x Buy
91%
1x Hold
9%

Analyst Opinions

11 Analysts have issued a MiMedx Group, Inc. forecast:

Buy
91%
Hold
9%

Financial data from MiMedx Group, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
352 352
5% 5%
100%
- Direct Costs 64 64
15% 15%
18%
289 289
3% 3%
82%
- Selling and Administrative Expenses 230 230
7% 7%
65%
- Research and Development Expense 13 13
12% 12%
4%
46 46
18% 18%
13%
- Depreciation and Amortization 0.67 0.67
12% 12%
0%
EBIT (Operating Income) EBIT 45 45
18% 18%
13%
Net Profit 40 40
36% 36%
11%

In millions USD.

Don't miss a Thing! We will send you all news about MiMedx Group, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

MiMedx Group, Inc. Stock News

Neutral
GlobeNewsWire
about 2 months ago
MARIETTA, Ga., May 27, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences: Craig-Hallum 22 nd Annual Institutional Investor Conference | Minneapolis, MN 1:1 sessions: Wednesday, May 28, 2025 Goldman Sachs 46 th Annual Global Healthcare Conference | Mia...
Neutral
GlobeNewsWire
2 months ago
MARIETTA, Ga., May 06, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the BofA Securities 2025 Healthcare Conference in Las Vegas, NV.
Neutral
GlobeNewsWire
2 months ago
Propensity Score-Matched, Comparative Cost-Effectiveness Analysis of the Company's EPIFIX® Placental Allograft Product Propensity Score-Matched, Comparative Cost-Effectiveness Analysis of the Company's EPIFIX® Placental Allograft Product
More MiMedx Group, Inc. News

Company Profile

MiMedx Group, Inc. is an advanced wound care and an emerging therapeutic biologics company. It engages in developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The company processes the human placental tissue utilizing its proprietary PURION process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. MiMedx Group was founded on July 30, 1985 and is headquartered in Marietta, GA.

Head office United States
CEO Joe Capper
Employees 895
Founded 1985
Website mimedx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today